Core Revision
Revision aid, not clinical advice. This page is educational material written for exam preparation. It is not a substitute for the current guideline or for clinical judgement, and must not be relied on for the care of any individual. Always check up-to-date national guidance and verify independently before acting on anything here.
Can you check FSH on the combined pill? Why the menopause test doesn’t work there
Dr Victoria HammondCo-Founder & Lead for Educational Design · 3 min read
Published 27 September 2026 · Checked against sources 28 September 2026
A woman in her forties, on the combined pill, asks whether she might be menopausal. It comes up in clinic and it comes up in exams — and the answer isn’t in the FSH. The reason is the whole point of the pill.
What you’ll take away
Why FSH can’t be read on combined hormonal contraception or HRT, when NICE does suggest it, and what to do instead.
1. The pill works by holding FSH down
The oestrogen and progestogen in combined hormonal contraception exert negative feedback while she uses the method. Follicular development is suppressed, so there is no oestradiol rise to trigger a surge. No surge, no ovulation. FSH is suppressed on purpose — so it can’t be interpreted on the pill, and NICE NG23 says so directly.
2. Her oestradiol looks low — but she isn’t oestrogen-deficient
Serum oestradiol is low on the combined pill, but she is oestrogenised by ethinylestradiol, which most oestradiol assays do not detect. A low oestradiol here means the method is working, not that she is menopausal. Qlaira and Zoely are the exception: they contain estradiol itself, which the assay does measure.
3. When NICE does suggest FSH
At 45 or over, NICE NG23 is explicit that the diagnosis is clinical: vasomotor symptoms with a change in periods are enough, and, in someone not using hormonal contraception, twelve months without a period confirms the menopause in retrospect. No FSH is needed. Consider FSH only at 40 to 45 with symptoms and a change in cycle, or under 40 where premature ovarian insufficiency is suspected — and for that, NICE asks for a raised FSH on two samples four to six weeks apart, never a single test.
Sitting the AKT? Try twenty questions free.
Twenty original AKT questions in the exam's 80/10/10 split: sixteen clinical, two on evidence-based practice and two on organisation and management, with the reasoning after every one and a marked report. Free, no card and the first five are open to all.
4. Where FSH can’t be read
It can’t be interpreted in anyone taking combined hormonal contraception or high-dose progestogen (NICE), or HRT (CoSRH, formerly FSRH): those hormones suppress FSH. On HRT, the oestradiol you measure mostly reflects the prescription. The measurement tells you about the prescription rather than about the ovary.
5. If a genuine menopause assessment is needed
CoSRH’s approach is to stop the combined method first and use a progestogen-only method in the interim, then measure FSH — the point for the exam is why: combined hormones suppress FSH, so the test cannot be read while they are being taken. A progestogen-only pill doesn’t invalidate an FSH in the way the combined pill does. CoSRH supports an FSH, to decide when contraception can stop, in women over 50 who have no periods on a progestogen-only method: above 30 IU/L, contraception continues for one more year, then stops. As a general guide, that level shows a degree of ovarian insufficiency, not necessarily sterility. On the injection, take it just before the next dose is due — and only a raised result can be trusted there, because the injection holds FSH down a little. NICE NG23 says not to use FSH on high-dose progestogen; CoSRH is the more specific of the two here.
Two things to keep beside this. HRT is not contraception. And in general, anyone can stop contraception at 55: spontaneous conception after that is exceptionally uncommon.
For the HRT side of the same consultation, the free HRT Reasoner in Core Tools works through it step by step.
When a question hands you an FSH, read the drug history before the number. If it includes combined hormonal contraception or HRT, the result is telling you about the prescription, not the ovary.
Dr Victoria Hammond · MBBS, BSc (Hons)
The HPO Axis Explorer takes the combined pill, HRT and the progestogen-only methods through the loop, with the CoSRH and NICE sources. It’s included with any Core Revision account, free or paid.
Sources & currency. Current at the time of writing (September 2026). Guidance evolves — always check the live guideline before applying it to a patient. A revision aid, not a substitute for the full guidelines or your own clinical judgement.
- NICE NG23. Menopause: identification and management (2015; last updated April 2026).
- College of Sexual and Reproductive Healthcare (CoSRH, formerly FSRH). Contraception for women aged over 40 years. August 2017, amended May 2025.
- College of Sexual and Reproductive Healthcare (CoSRH, formerly FSRH). Combined Hormonal Contraception. January 2019, amended October 2023.
- HPO Axis Explorer (Core Revision): combined hormonal contraception; menopause and perimenopause; HRT; progestogen-only pill; injection.
Written by practising UK GPs — Dr Victoria Hammond and Dr David Palethorpe. Education only — always confirm against current guidance. Core Revision is an independent revision resource.
